Entropy Neurodynamics Limited has released a press release.
Appendix 4C - quarterly
Filed with ASX ·
6ix hasn’t read this filing yet.
Entropy Neurodynamics Limited on 6ix
Earlier from Entropy Neurodynamics
- Appendix 4E and Annual Financial Report FY 2019
- PLEXOVAL Exosome Wound Healing Human Study Starts
- Share Purchase Plan 2019 Offer Document
- Share Placement and Share Purchase Plan Announced
- Securures Ethics Approval for Plexoval Clinical Trial
Later from Entropy Neurodynamics
- Appointment of Chief Commercial Officer
- Development Program Update
- Key Management Contracts Extended
- First Dosing in PLEXOVAL Exosome Wound Healing Human Study
- December Quarterly Report and Appendix 4C
Follow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics